S'abonner

Genome-wide association study of lung function decline in adults with and without asthma - 28/04/12

Doi : 10.1016/j.jaci.2012.01.074 
Medea Imboden, PhD a, b, , Emmanuelle Bouzigon, MD, PhD c, d, e, , Ivan Curjuric, MD a, b, Adaikalavan Ramasamy, PhD f, Ashish Kumar, MSc a, b, g, Dana B. Hancock, PhD h, i, Jemma B. Wilk, DSc j, Judith M. Vonk, PhD k, Gian A. Thun, MSc a, b, Valerie Siroux, PhD l, m, Rachel Nadif, PhD n, o, Florent Monier, MSc c, d, e, Juan R. Gonzalez, PhD p, q, Matthias Wjst, MD, MD r, Joachim Heinrich, PhD r, Laura R. Loehr, MD, PhD s, Nora Franceschini, MD, MPH s, Kari E. North, PhD t, Janine Altmüller, MD u, Gerard H. Koppelman, MD, PhD k, Stefano Guerra, MD, PhD p, q, v, cc, Florian Kronenberg, MD w, Mark Lathrop, PhD d, x, Miriam F. Moffatt, DPhil y, George T. O’Connor, MD, MSc z, aa, David P. Strachan, MD bb, Dirkje S. Postma, MD, PhD k, Stephanie J. London, MD, DrPH h, Christian Schindler, PhD a, b, Manolis Kogevinas, MD p, q, cc, dd, Francine Kauffmann, MD n, o, Debbie L. Jarvis, MD f, Florence Demenais, MD c, d, e, Nicole M. Probst-Hensch, PhD a, b,
a Swiss Tropical and Public Health Institute, Basel, Switzerland 
b University of Basel, Basel, Switzerland 
c Inserm, UMRS-946, Paris, France 
d Fondation Jean Dausset–Centre d’Etude du Polymorphisme Humain (CEPH), Paris, France 
e Université Paris Diderot, Paris 7, Institut Universitaire d’Hématologie, Paris, France 
f Respiratory Epidemiology and Public Health, Imperial College, and MRC-HPA Centre for Environment and Health, London, United Kingdom 
g Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom 
h Epidemiology Branch, Division of Intramural Research, National Institute of Environmental Health Sciences, National Institutes of Health, Department of Health and Human Services, Research Triangle Park, NC 
i Behavioral Health Epidemiology Program, Research Triangle Institute International, Research Triangle Park, NC 
j Departments of Neurology and Medicine, Boston University School of Medicine, Boston, Mass 
k Department of Pulmonology, Pediatric Pulmonology and Pediatric Allergology, Epidemiology, Beatrix Children’s Hospital, Groningen Research Institute for Asthma and COPD, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands 
l Team of Environmental Epidemiology applied to Reproduction and Respiratory Health, Inserm, U823, Grenoble, France 
m Université Joseph Fourier, Grenoble, France 
n Inserm, U1018, CESP Centre for Research in Epidemiology and Population Health, Respiratory and Environmental Epidemiology Team, Villejuif, France 
o Université Paris Sud, UMRS 1018, Villejuif, France 
p Centre for Research in Environmental Epidemiology, Barcelona, Spain 
q CIBER Epidemiologia y Salúd Publica, Barcelona, Spain 
r Institute of Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany 
s Department of Epidemiology, UNC Gillings School of Global Public Health, University of North Carolina–Chapel Hill, Chapel Hill, NC 
t Department of Epidemiology and Carolina Center for Genome Sciences, University of North Carolina–Chapel Hill, Chapel Hill, NC 
u Cologne Center for Genomics (CCG), University of Cologne, Cologne, Germany 
v Arizona Respiratory Center, University of Arizona, Tucson, Ariz 
w Department of Medical Genetics, Molecular and Clinical Pharmacology, Division of Genetic Epidemiology, Innsbruck Medical University, Innsbruck, Austria 
x Commissariat à l’Energie Atomique, Institut de Génomique, Centre National de Génotypage, Evry, France 
y National Heart and Lung Institute, Imperial College, London, United Kingdom 
z Pulmonary Center, Department of Medicine, Boston University School of Medicine, Boston, Mass 
aa National Heart, Lung, and Blood Institute’s Framingham Heart Study, Framingham, Mass 
bb Division of Population Health Sciences and Education, St George’s, University of London, London, United Kingdom 
cc IMIM (Municipal Institute of Medical Research), Barcelona, Spain 
dd National School of Public Health, Athens, Greece 

Corresponding author: Nicole M. Probst-Hensch, PhD, SwissTPH, Socinstr. 57, 4002 Basel, Switzerland.

Abstract

Background

Genome-wide association studies have identified determinants of chronic obstructive pulmonary disease, asthma, and lung function level; however, none have addressed decline in lung function.

Objective

We conducted the first genome-wide association study on the age-related decrease in FEV1 and its ratio to forced vital capacity (FVC) stratified a priori by asthma status.

Methods

Discovery cohorts included adults of European ancestry (1,441 asthmatic and 2,677 nonasthmatic participants: the Epidemiological Study on the Genetics and Environment of Asthma, the Swiss Cohort Study on Air Pollution and Lung and Heart Disease in Adults, and the European Community Respiratory Health Survey). The associations of FEV1 and FEV1/FVC ratio decrease with 2.5 million single nucleotide polymorphisms (SNPs) were estimated. Thirty loci were followed up by in silico replication (1,160 asthmatic and 10,858 nonasthmatic participants: Atherosclerosis Risk in Communities, the Framingham Heart Study, the British 1958 Birth Cohort, and the Dutch Asthma Study).

Results

Main signals identified differed between asthmatic and nonasthmatic participants. None of the SNPs reached genome-wide significance. The association between the height-related gene DLEU7 and FEV1 decrease suggested for nonasthmatic participants in the discovery phase was replicated (discovery, P = 4.8 × 10−6; replication, P = .03), and additional sensitivity analyses point to a relation to growth. The top ranking signal, TUSC3, which is associated with FEV1/FVC ratio decrease in asthmatic participants (P = 5.3 × 10−8), did not replicate. SNPs previously associated with cross-sectional lung function were not prominently associated with decline.

Conclusions

Genetic heterogeneity of lung function might be extensive. Our results suggest that genetic determinants of longitudinal and cross-sectional lung function differ and vary by asthma status.

Le texte complet de cet article est disponible en PDF.

Key words : Asthma, cohort studies, genome-wide association, lung function decline, heterogeneity

Abbreviations used : ARIC, B58C, COPD, ECRHS, EGEA, FHS, FVC, GWAS, SAPALDIA, SNP


Plan


 Information on support for this research is provided in the acknowledgments section of this article.
 Disclosure of potential conflict of interest: J. B. Wilk has received research support from the National Institutes of Health/National Heart, Lung, and Blood Institute and the Flight Attendant Medical Research Institute. G. H. Koppelman has received research support from the Netherlands Asthma Foundation. D. S. Postma is a consultant for Nycomed and has received research support from the Top Institute Pharma and AstraZeneca. F. Kauffmann has received research support from the French Agency of Research, French Agency for Environmental and Occupational Health and Safety, and INSERM−Ministry of Research “Cohortes et Collections.” The rest of the authors declare that they have no relevant conflicts of interest.


© 2012  American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 129 - N° 5

P. 1218-1228 - mai 2012 Retour au numéro
Article précédent Article précédent
  • The Editors’ Choice
  • Donald Y.M. Leung, Stanley J. Szefler, Associate Editors of the JACI
| Article suivant Article suivant
  • Effect of asthma exacerbations on health care costs among asthmatic patients with moderate and severe persistent asthma
  • Jasmina I. Ivanova, Rachel Bergman, Howard G. Birnbaum, Gene L. Colice, Robert A. Silverman, Kimmie McLaurin

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.